Bristol-Myers Squibb Company
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $18.30B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $400.1M | 2.2% |
| Business Acquisitions | $386.9M | 2.1% |
| Dividends Paid | $2.63B | 14.4% |
| Stock Repurchases | $2.86B | 15.6% |
| Net Change in Short-Term Borrowings | $66.6M | 0.4% |
| Working Capital | $4.44B | 24.3% |
| Other | $5.32B | 29.0% |
| Net Cash Flow | $2.19B | 12.0% |